120
Participants
Start Date
October 27, 2023
Primary Completion Date
March 31, 2028
Study Completion Date
July 31, 2028
177Lu-edotreotide
6 cycles of 7.5 ± 0.7 Giga becquerel (GBq) 177Lu-edotreotide
Everolimus
10 mg orally once daily (QD)
RECRUITING
Antwerp University Hospital (UZA), Edegem
RECRUITING
Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France, Marseille
RECRUITING
Istituto Europeo di Oncologia - Milano, Milan
RECRUITING
Hospital Center University Dijon Bourgogne (CHU Bourgogne), Dijon
RECRUITING
Hospital General Universitario Gregorio Marañón, Madrid
RECRUITING
Hospital Universitario Ramón y Cajal, Madrid, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela
RECRUITING
Centre Hospitalier Universitaire (CHU) Bordeux, Bourdeaux
RECRUITING
Hospital Universitario Central de Asturias, Oviedo
RECRUITING
Department of Digestive Oncology, CHU Saint Eloi, Montpellier, France/ ICM Cancer Institute at Montpellier, Montpellier
NOT_YET_RECRUITING
Azienda Ospedaliera Universitaria Integrata Verona, Verona
RECRUITING
Hospital Universitario Virgen del Rocío, Seville
RECRUITING
Azienda USL IRCCS Di Reggio Emilia, Reggio Emilia
RECRUITING
Centre Hospitalier Universitaire de Nantes, Nantes
RECRUITING
Hospital Universitario y Politécnico La Fe, Valencia
RECRUITING
"IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - Irsì - Meldola", Meldola
RECRUITING
Lille University Hospital, Lille
RECRUITING
Hôpital Edouard Herriot, Lyon, Lyon
RECRUITING
I. Gustave Roussy, Paris, Paris
NOT_YET_RECRUITING
Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence Rome, Rome, Italy., Roma
RECRUITING
ICO Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
ITM Oncologics GmbH
INDUSTRY
MFAR
OTHER
Grupo Espanol de Tumores Neuroendocrinos
OTHER